Publications by authors named "Wenxi Yan"

Article Synopsis
  • The investigation aimed to identify the active compounds in airpotato yam rhizome (AYR) and how they could potentially treat colorectal cancer (CRC).
  • Using network pharmacology and molecular docking, researchers predicted that quercetin in AYR primarily targets EGFR and AKT1, crucial in the EGF/EGFR-induced PI3K/AKT pathway.
  • In experiments, AYR showed the ability to inhibit the PI3K/AKT pathway, leading to increased cancer cell death in both cell cultures and mouse models, suggesting its promise as a CRC treatment.
View Article and Find Full Text PDF

Purpose Of Review: This overview aims to reevaluate the methodological quality, report quality, and evidence quality of systematic reviews (SRs)/meta-analyses (MAs) of acupuncture for low back pain to determine whether acupuncture effectively treats low back pain (LBP).

Recent Findings: Twenty-three SRs/MAs were deemed eligible for the present overview. The AMSTAR 2 score showed that the methodological quality of one SR/MA was of medium quality, one was of low quality, and 21 were of critically low quality.

View Article and Find Full Text PDF

External therapy of traditional Chinese medicine and paraffin therapy are both traditional Chinese forms of treatment. In recent years, external use of traditional Chinese medicine combined with paraffin therapy, which involves combining meridians, acupoints, drugs, and hyperthermia, has demonstrated great effectiveness in treating certain conditions. An overview of traditional Chinese medicine paraffin therapy (TCMPT) is provided by this article.

View Article and Find Full Text PDF

Background: Colon cancer is a worldwide leading cause of cancer-related mortality, and the prognosis of colon cancer is still needed to be improved. This study aimed to construct a prognostic model for predicting the prognosis of colon cancer.

Methods: The gene expression profile data of colon cancer were obtained from the TCGA, GSE44861, and GSE44076 datasets.

View Article and Find Full Text PDF

To engineer tumor-tropic cells as drug delivery vehicles is a promising strategy to improve therapeutic specificity and efficacy for cancer treatment. However, conventional genetically engineered cell-based drug delivery systems are often capable of initiating single-mode therapy, and lack precise spatiotemporal control over the release of therapeutic payloads at tumor local, thus possibly causing severe systemic toxicity. Here, the macrophages are genetically engineered to encode a non-secreted form of EGFP-TNFα fusion protein and intracellularly carry near-infrared (NIR)-responsive heat-nanogenerators (HIMs).

View Article and Find Full Text PDF